A review of tocilizumab treatment in 122 rheumatoid arthritis patients included in the Tsurumai Biologics Communication Registry (TBCR) Study
Modern Rheumatology,  Clinical Article

Yabe Y et al. – When used as a first–line biological drug for patients with early–stage RA (≤12 M), tocilizumab appears to provide high rates of remission under the Boolean–based remission criterion, which were strongly affected by the patient global assessment (PtGA).

Methods
  • Using data from the Tsurumai Biologics Communication Registry for 122 patients treated with tocilizumab, the authors evaluated changes in DAS28–ESR at 12 months after initiation, and also evaluated remission rates defined using conventional and new Boolean–based remission criteria.
  • They divided 50 patients who had received tocilizumab as a first–line treatment into two groups [disease duration at baseline of 12 months or less (≤12 M) and more than 12 months (>12 M)].

Results
  • At 12 months after initiation, there was no difference in DAS28–ESR, and remission rates based on the conventional criterion were also comparable (50 % in both groups).
  • However, under the new criterion, remission was 50.0 % in the ≤12 M group against 12.5 % in the >12 M group (p = 0.0181).
  • Among the individual components of the new remission criterion, the small proportion of patients in the >12 M group with a patient global assessment (PtGA) of ≤1 had a particularly strong influence on the remission rate for that group, but this component was not as important for the ≤12 M group.

Please login or register to follow this author.
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Rheumatology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Rheumatology Articles

1 Homeopathy in the treatment of fibromyalgia- A comprehensive literature-review and meta-analysis Complementary Therapies in Medicine, August 15, 2014    Evidence Based Medicine    Review Article

2 Coffee or tea consumption and the risk of rheumatoid arthritis: A meta-analysis Clinical Rheumatology, October 15, 2014    Clinical Article

3 The comparative safety of TNF inhibitors in rheumatoid arthritis - a meta-analysis update of 44 randomized controlled trials American Journal of Medicine, October 6, 2014    Clinical Article

4 Drug-associated cutaneous vasculitis: Study of 239 patients from a single referral center The Journal of Rheumatology, September 25, 2014    Clinical Article

5 Rituximab for the treatment of relapses in ANCA-associated vasculitis Arthritis & Rheumatism, August 1, 2014    Clinical Article

6 Lupus classification criteria expanded; treat-to-target approach gains support Full Text The Rheumatologist, July 24, 2014    Free full text

7 Fish consumption and risk of rheumatoid arthritis: A dose-response meta-analysis Arthritis Research & Therapy, October 8, 2014    Evidence Based Medicine    Review Article

8 The impact of statins therapy on disease activity and inflammatory factor in patients with rheumatoid arthritis: A meta-analysis Clinical and Experimental Rheumatology Online, October 27, 2014    Evidence Based Medicine    Clinical Article

9 Efficacy and safety of ginger in osteoarthritis patients: A meta-analysis of randomized placebo-controlled trials Osteoarthritis and Cartilage , October 28, 2014    Evidence Based Medicine    Clinical Article

10 Early predictors of prognosis in juvenile idiopathic arthritis: A systematic literature review Annals of Rheumatic Diseases, August 29, 2014    Review Article

11 Homeopathy in the treatment of fibromyalgia—A comprehensive literature-review and meta-analysis Complementary Therapies in Medicine, October 9, 2014    Clinical Article

12 Alcohol consumption as a preventive factor for developing rheumatoid arthritis: A dose-response meta-analysis of prospective studies Annals of Rheumatic Diseases, October 24, 2014    Evidence Based Medicine    Clinical Article

13 Cost-utility of cognitive behavioural therapy versus U.S. food and drug administration recommended drugs and usual care in the treatment of patients with fibromyalgia: An economic evaluation alongside a 6-month randomised controlled trial Arthritis Research & Therapy, October 7, 2014    Clinical Article

14 Baseline serum level of matrix metalloproteinase-3 as a biomarker of progressive joint damage in rheumatoid arthritis patients International Journal of Rheumatic Diseases, October 17, 2014    Clinical Article

15 Targeted treatment with a combination of traditional DMARDs produces excellent clinical and radiographic long-term outcomes in early rheumatoid arthritis regardless of initial infliximab: The 5-year follow-up results of a randomised clinical trial, the NEO-RACo trial Annals of Rheumatic Diseases, October 23, 2014    Clinical Article

16 Low-dose pulse cyclophosphamide in interstitial lung disease associated with systemic sclerosis (SSc-ILD) - efficacy of maintenance immunosuppression in responders and non-responders Seminars in Arthritis and Rheumatism, September 30, 2014    Clinical Article

17 Vitamin D deficiency is associated with progression of knee osteoarthritis The Journal of Nutrition, October 10, 2014    Clinical Article

18 Oral bisphosphonate use and total knee/hip implant survival: Validation of results in an external population-based cohort Arthritis & Rheumatism, August 14, 2014    Clinical Article

19 Lipid profile changes in patients with chronic inflammatory arthritis treated with biologics and tofacitinib in randomized clinical trials: A systematic review and meta-analysis Arthritis & Rheumatism, October 14, 2014    Evidence Based Medicine    Review Article

20 Efficacy of a natural mineral complex in North American adults with osteoarthritis of the knee: A randomized double-blind placebo-controlled study Full Text Open Access Rheumatology: Research and Reviews, October 13, 2014    Free full text    Clinical Article

Indexed Journals in Rheumatology: Arthritis & Rheumatism, Annals of Rheumatic Diseases, Journal of Rheumatologymore